QCLSQ/C Technologies Inc. Common Stock

2.580USD-5.49%Mkt Cap: 21.13M $P/E:

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that r…

Key Statistics

Company
Market Cap21.13M $
Enterprise Value14.87M $
Revenue (TTM)
Gross Profit0 $
Net Income (TTM)-11.63M $
Revenue/Share
Last Price2.580 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryComputer Hardware
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B1.40
EPS (TTM)-92.99
EPS (Forward)
52W Range
2.5001% of range10.10
52W High10.10 USD
52W Low2.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.45%
ROA-28.24%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-9.07M $
CapEx (TTM)2.01M $
FCF Margin
FCF Yield-28.18%
Net Debt-10.62M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity0.00
Current Ratio3.29
Quick Ratio3.09
Book Value/Sh1.947 USD
Cash/Share1.342 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:100
Split DateSep 2, 2025
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.8.19M
Float8.11M
Insiders7.53%
Institutions9.02%
Short Interest
Short Ratio6.8d
Short % Float103.08%
Short % Out.19.09%
Shares Short1.50M
Short (prev mo.)1.53M
Technical
SMA 503.347 (-22.9%)
SMA 2003.866 (-33.3%)
Beta2.11
S&P 52W Chg18.16%
Avg Vol (30d)153.79K
Avg Vol (10d)101.40K
Technical Indicators
RSI (14)34.8
MACD-0.1815
MACD Signal-0.1907
MACD Hist.+0.0092
BB Upper3.187 USD
BB Middle2.825 USD
BB Lower2.464 USD
BB Width25.60%
ATR (14)0.2076 USD
Vol Ratio (20d)1.20x